Outcomes after extracorporeal membrane oxygenation support in COVID‐19 and non‐COVID‐19 patients
| Autor: | G. R. Scott Budinger, Samuel Kim, James M. Walter, Ankit Bharat, Alexandra Klonis, Adwaiy Manerikar, Azad S. Karim, Chitaru Kurihara, Mark Saine, Vanessa Hoppner, Satoshi Watanabe, Viswajit Kandula, Rafael Garza-Castillon, Kalvin Lung, David D. Odell, Catherine A Gao, Richard G. Wunderink |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
ARDS
Time Factors Coronavirus disease 2019 (COVID-19) medicine.medical_treatment Biomedical Engineering Medicine (miscellaneous) Bioengineering Hemorrhage V‐V ECMO outcomes Extracorporeal Biomaterials Extracorporeal Membrane Oxygenation COVID‐19 circulatory support devices medicine Extracorporeal membrane oxygenation Lung transplantation Humans In patient Late initiation Retrospective Studies Respiratory Distress Syndrome Main Text artificial organs business.industry COVID-19 General Medicine medicine.disease surgical procedures operative Anesthesia business Thrombotic complication |
| Zdroj: | Artificial Organs |
| ISSN: | 1525-1594 0160-564X |
| Popis: | Background Veno‐venous extracorporeal membrane oxygenation (V‐V ECMO) support is increasingly used in the management of COVID‐19‐related acute respiratory distress syndrome (ARDS). However, the clinical decision‐making to initiate V‐V ECMO for severe COVID‐19 still remains unclear. In order to determine the optimal timing and patient selection, we investigated the outcomes of both COVID‐19 and non‐COVID‐19 patients undergoing V‐V ECMO support. Methods Overall, 138 patients were included in this study. Patients were stratified into two cohorts: those with COVID‐19 and non‐COVID‐19 ARDS. Results The survival in patients with COVID‐19 was statistically similar to non‐COVID‐19 patients (p = .16). However, the COVID‐19 group demonstrated higher rates of bleeding (p = .03) and thrombotic complications (p The survival in patients with COVID‐19 was statistically similar compared to non‐COVID‐19 patients, but the mortality of COVID‐19 patients who had been on a ventilator for longer than 7 days prior to the initiation of ECMO approached 100%. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text